Healthcare · Pharmaceuticals & Biotechnology
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 3,933† | — | 3,531† | 3,318† | 3,441† |
| Net profit | 1,012 | 919 | 585 | 608 | — |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Bhushan Akshikar | Executive Director | June 30, 2026 |
| Ronojit Biswas | Executive Director | June 30, 2026 |
| Anup Wadhawan | Independent Director | June 30, 2026 |
| Manu Anand | Independent Director | June 30, 2026 |
| Somasundaram Palamadairamaswamy | Independent Director | June 30, 2026 |
| Sunita Maheshwari | Independent Director | June 30, 2026 |
| Renu Sud Karnad | Non-Executive Director | June 30, 2026 |
| Subesh Williams | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
